Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
CA 2441287 C · Owner: Boyd, Michael R. · Inventors: Mori, Toshiyuki; Boyd, Michael R.; O'Keefe, Barry R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An isolated and purified nucleic acid molecule that encodes a protein or peptide comprising at least nine contiguous amino acids of SEQ ID NO:2 wherein the at least nine contiguous amino acids comprise amino acids 30-32 of SEQ ID NO:2 which have been rendered glycosylation resistant and wherein the at least nine contiguous amino acids have antiviral activity a vector , comprising such an isolated and purified nucleic acid molecule a host cell or , organism comprising the vector a method of producing an antiviral protein or antiviral peptide, the antiviral protein or antiviral peptide itself a , conjugate comprising the antiviral protein or antiviral peptide and , compositions comprising …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 22, 2002 and granted June 10, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.